Alcobra Ltd. (ADHD) Misses Q3 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. LEVI
2. APLD
3. STZ
4. SPY
5. GOOGL
6. RMR
7. SPCX
8. DVN
9. CRGY
10. GOOG

Go back to Alcobra Ltd. (ADHD) Misses Q3 EPS by 2c

Alcobra Announces Third Quarter 2016 Financial Results and Provides Corporate Update

November 15, 2016 7:30 AM EST

Conference Call & Webcast November 15th at 8:30 a.m. Eastern Time/5:30 a.m. Pacific Time

TEL AVIV, Israel, Nov. 15, 2016 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq: ADHD), an emerging pharmaceutical company focused on the development of new medications to treat patients with cognitive disorders, including Attention Deficit Hyperactivity Disorder (ADHD) and Fragile X Syndrome, today announced financial results for the three and nine months ended September 30, 2016, and provided a corporate update.

Third Quarter Ended September 30, 2016 Financial Results:

Total operating expenses in the third quarter 2016 were $7.9... More